Drug intelligence / Profile preview

Bawei Rougui Capsules

Development stage: Unknown
Lead developer: Yunnan Yongzitang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Bawei Rougui Capsules (八味肉桂胶囊) is a traditional Chinese medicine (TCM) manufactured by Yunnan Yongzitang, a subsidiary of Hunan Hansen Pharmaceutical. It is an approved herbal formulation provided in an oral capsule dosage form. As a traditional herbal product, it does not have a single defined molecular mechanism of action or specific protein targets; instead, its therapeutic profile is derived from the synergistic effects of its constituent herbal ingredients according to TCM principles. It is classified by the manufacturer as an 'exclusive variety' (独家品种).

Brand names: Bawei Rougui Capsules八味肉桂胶囊
Other names: Bawei Rougui Jiaonang

Beyond the preview

Go deeper on Bawei Rougui Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bawei Rougui Capsules.

Explore the full profile